search
Back to results

The Effect of a Botanical Plant Extract on Gut Health, Immunity and Metabolic Disorders in Healthy Adults (GHIMD)

Primary Purpose

Healthy

Status
Recruiting
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Low dose response efficacy of plant extracts
Middle dose response efficacy of plant extracts
High Dose response efficacy of plant extracts
Placebo
Sponsored by
University of Roehampton
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Healthy

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion criteria

  • Females and males, aged 18 years to 65 years
  • Body Mass Index (BMI) 27-35 kg/m2
  • Not dieting within the last month and not having lost >5% body weight in the previous year
  • Not increased physical activity levels in the past 2-4 weeks or intending to modify them during the study
  • Understands and is willing, able and likely to comply with all study procedures and restriction including being willing to follow the nutritional advice
  • Able to eat most everyday foods
  • Habitually consumes three standard meals a day (i.e. breakfast, lunch and dinner)

Exclusion criteria

  • Significant health problems (e.g. hypercholesterolaemia, diabetes, GI disorders)
  • Taking any medication or supplements known to affect mineral or glucose metabolism within the past month and/or during the study
  • Pregnant, planning to become pregnant or breastfeeding
  • History of anaphylaxis to food
  • Known allergies or intolerance to foods and/or to the study materials (or closely related compounds) or any of their stated ingredients
  • BMI <27 kg/m2 or >35 kg/m2
  • Volunteers self-reporting currently dieting or having lost >5% body weight in the previous year
  • Participants with abnormal eating behaviour
  • Participation in another experimental study or receipt of an investigational drug/product within 30 days of the screening visit
  • Volunteers who have significantly changed their physical activity in the past 2-4 weeks or who intend to change them during the study
  • Participants receiving systemic or local treatment likely to interfere with the evaluation of the study parameters
  • Participants on specific food avoidance diets
  • Participants who work in appetite or feeding related areas

Sites / Locations

  • Health Sciences Research Centre, Life Sciences Department, University of RoehamptonRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Active Comparator

Active Comparator

Active Comparator

Placebo Comparator

Arm Label

Low dose plant extract

Middle dose plant extract

High Dose plant extract

Placebo control

Arm Description

300 mg

500 mg

700 mg

Cellulose microcrystalline

Outcomes

Primary Outcome Measures

Body weight Measurements
Weight in kilograms
Body mass Index measurements
kg/m^2
Monitoring Blood pressure changes
mm/Hg
Microbiota composition
DNA profiling from faeces (bacteria numbers/g faeces)
Modulation of blood lipids
Effects on TC, LDL-C, HDL-C and TAG expressed in mmol/L
Changes in insulin
Effect of insulin levels expressed in mg/dl
Modulation of immune function by plant extracts
Cytokines analysis on IL6,IL10, IL2 and TNFa expressed in pg/mL

Secondary Outcome Measures

Dietary assessment
Food Dietary intake analysis via DietPlan 7

Full Information

First Posted
April 12, 2019
Last Updated
May 31, 2023
Sponsor
University of Roehampton
search

1. Study Identification

Unique Protocol Identification Number
NCT03921333
Brief Title
The Effect of a Botanical Plant Extract on Gut Health, Immunity and Metabolic Disorders in Healthy Adults
Acronym
GHIMD
Official Title
Double Blind Randomised Placebo Controlled Investigation Into the Effect of Supplementing Plant Extracts on Gut Health, Immunity and Metabolic Disorders in Healthy Adults
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
October 28, 2019 (Actual)
Primary Completion Date
December 28, 2023 (Anticipated)
Study Completion Date
January 25, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Roehampton

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
There is an enormous increase in diabetes mellitus worldwide, especially in developed countries. Ninety percent of diabetes cases worldwide are of Type II diabetes mellitus (T2DM) as a result of greater prevalence of sedentary lifestyle, unhealthy diet and rise of obesity, as well as an increasing number of elderly populations. T2DM can be attributed to relative deficiency of insulin involving insulin resistance, aberrant synthesis of hepatic glucose and progressive deterioration of pancreatic beta-cell functions resulting in chronic hyperglycaemia. A growing amount of evidence has emerged in the last several years linking various nutrients and food sources with a positive management of T2DM. In in vitro studies, various botanical extracts have been found to significantly inhibit the activity of alpha-glucosidase and alpha-amylase. The inhibition of these enzymes' activity is a rational approach in managing glucose level for borderline and T2DM sufferers as inhibition of both alpha-amylase and alpha-glucosidase activity can profoundly reduce post-prandial increase in blood plasma glucose concentration following a mixed carbohydrate intake. Excessive levels of blood plasma glucose and free fatty acids impose a stressful condition for pancreatic beta-cells and other insulin sensitive cells resulting in the local secretion of pro-inflammatory cytokines and chemokines causing a continuous low levels of abnormal inflammation that alter insulin's action. As the body becomes less sensitive to insulin, the resulting insulin resistance leads to further inflammation, with more inflammation causing more insulin resistance, causing blood plasma sugar levels to continuously increase, eventually resulting in T2DM. In in vitro animal models, various compounds of botanical origin have also been shown to possess anti-inflammatory activities which can be beneficial in managing T2DM.
Detailed Description
The aim of this human intervention study is to evaluate the impact of a botanical-based extract on gut health, immunity and metabolic disorders in healthy adults.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Healthy

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Dose response study
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
52 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Low dose plant extract
Arm Type
Active Comparator
Arm Description
300 mg
Arm Title
Middle dose plant extract
Arm Type
Active Comparator
Arm Description
500 mg
Arm Title
High Dose plant extract
Arm Type
Active Comparator
Arm Description
700 mg
Arm Title
Placebo control
Arm Type
Placebo Comparator
Arm Description
Cellulose microcrystalline
Intervention Type
Dietary Supplement
Intervention Name(s)
Low dose response efficacy of plant extracts
Other Intervention Name(s)
Low dose
Intervention Description
300mg
Intervention Type
Dietary Supplement
Intervention Name(s)
Middle dose response efficacy of plant extracts
Other Intervention Name(s)
Middle dose
Intervention Description
500mg
Intervention Type
Dietary Supplement
Intervention Name(s)
High Dose response efficacy of plant extracts
Other Intervention Name(s)
High Dose
Intervention Description
700mg
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo
Other Intervention Name(s)
Placebo control
Intervention Description
Cellulose microcrystalline
Primary Outcome Measure Information:
Title
Body weight Measurements
Description
Weight in kilograms
Time Frame
Changes from baseline to 4 and 8 week treatment period with plant extracts
Title
Body mass Index measurements
Description
kg/m^2
Time Frame
Changes from baseline to 4 and 8 week treatment period with plant extracts
Title
Monitoring Blood pressure changes
Description
mm/Hg
Time Frame
Changes from baseline to 4 and 8 week treatment period with plant extracts
Title
Microbiota composition
Description
DNA profiling from faeces (bacteria numbers/g faeces)
Time Frame
Changes from baseline to 4 and 8 week treatment period with plant extracts
Title
Modulation of blood lipids
Description
Effects on TC, LDL-C, HDL-C and TAG expressed in mmol/L
Time Frame
Changes from baseline to 4 and 8 week treatment period with plant extracts
Title
Changes in insulin
Description
Effect of insulin levels expressed in mg/dl
Time Frame
Changes from baseline to 4 and 8 week treatment period with plant extracts
Title
Modulation of immune function by plant extracts
Description
Cytokines analysis on IL6,IL10, IL2 and TNFa expressed in pg/mL
Time Frame
Changes from baseline to 4 and 8 week treatment period with plant extracts
Secondary Outcome Measure Information:
Title
Dietary assessment
Description
Food Dietary intake analysis via DietPlan 7
Time Frame
Changes from baseline to 4 and 8 week treatment period with plant extracts

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion criteria Females and males, aged 18 years to 65 years Body Mass Index (BMI) 27-35 kg/m2 Not dieting within the last month and not having lost >5% body weight in the previous year Not increased physical activity levels in the past 2-4 weeks or intending to modify them during the study Understands and is willing, able and likely to comply with all study procedures and restriction including being willing to follow the nutritional advice Able to eat most everyday foods Habitually consumes three standard meals a day (i.e. breakfast, lunch and dinner) Exclusion criteria Significant health problems (e.g. hypercholesterolaemia, diabetes, GI disorders) Taking any medication or supplements known to affect mineral or glucose metabolism within the past month and/or during the study Pregnant, planning to become pregnant or breastfeeding History of anaphylaxis to food Known allergies or intolerance to foods and/or to the study materials (or closely related compounds) or any of their stated ingredients BMI <27 kg/m2 or >35 kg/m2 Volunteers self-reporting currently dieting or having lost >5% body weight in the previous year Participants with abnormal eating behaviour Participation in another experimental study or receipt of an investigational drug/product within 30 days of the screening visit Volunteers who have significantly changed their physical activity in the past 2-4 weeks or who intend to change them during the study Participants receiving systemic or local treatment likely to interfere with the evaluation of the study parameters Participants on specific food avoidance diets Participants who work in appetite or feeding related areas
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Adele Costabile, Dr
Phone
02083923571
Ext
3571
Email
adele.costabile@roehampton.ac.uk
First Name & Middle Initial & Last Name or Official Title & Degree
Enver Keleszade, Mr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Adele Costabile, Dr
Organizational Affiliation
University of Roehampton
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Steve Trangmar, Dr
Organizational Affiliation
University of Roehampton
Official's Role
Study Director
Facility Information:
Facility Name
Health Sciences Research Centre, Life Sciences Department, University of Roehampton
City
London
State/Province
UK
ZIP/Postal Code
SW15 4JD
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Adele Costabile

12. IPD Sharing Statement

Learn more about this trial

The Effect of a Botanical Plant Extract on Gut Health, Immunity and Metabolic Disorders in Healthy Adults

We'll reach out to this number within 24 hrs